Literature DB >> 15678407

Modelling the incubation period of anthrax.

Ron Brookmeyer1, Elizabeth Johnson, Sarah Barry.   

Abstract

Models of the incubation period of anthrax are important to public health planners because they can be used to predict the delay before outbreaks are detected, the size of an outbreak and the duration of time that persons should remain on antibiotics to prevent disease. The difficulty is that there is little direct data about the incubation period in humans. The objective of this paper is to develop and apply models for the incubation period of anthrax. Mechanistic models that account for the biology of spore clearance and germination are developed based on a competing risks formulation. The models predict that the incubation period distribution depends critically on the rate that spores are cleared from the lung and to a lesser extent on the dose of inhaled spores. The models are used in a statistical analysis of data from an anthrax outbreak that occurred in Sverdlovsk, Russia. The analysis suggests that spores are cleared from the lung at a rate between 8 per cent per day and 14 per cent per day, which is in good agreement with experimental studies of animals. The analysis suggests that at low doses, the overall median incubation period time is about 10 days, which includes a median lag of about 2 days between spore germination and onset of symptoms. Male gender and younger ages were associated with longer incubation periods as was lower dose of inhaled spores. Copyright 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2005        PMID: 15678407     DOI: 10.1002/sim.2033

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  24 in total

1.  A dynamic dose-response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax.

Authors:  Bryan T Mayer; James S Koopman; Edward L Ionides; Josep M Pujol; Joseph N S Eisenberg
Journal:  J R Soc Interface       Date:  2010-11-10       Impact factor: 4.118

2.  Sverdlovsk revisited: modeling human inhalation anthrax.

Authors:  Dean A Wilkening
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-05       Impact factor: 11.205

Review 3.  A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.

Authors:  Joseph R Egan; Ian M Hall
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

4.  Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.

Authors:  Marybeth Langer; Elizabeth Stewart Duggan; John Leland Booth; Vineet Indrajit Patel; Ryan A Zander; Robert Silasi-Mansat; Vijay Ramani; Tibor Zoltan Veres; Frauke Prenzler; Katherina Sewald; Daniel M Williams; Kenneth Mark Coggeshall; Shanjana Awasthi; Florea Lupu; Dennis Burian; Jimmy Dale Ballard; Armin Braun; Jordan Patrick Metcalf
Journal:  Infect Immun       Date:  2012-10-01       Impact factor: 3.441

5.  Humoral and Cell-Mediated Immune Responses to Alternate Booster Schedules of Anthrax Vaccine Adsorbed in Humans.

Authors:  Conrad P Quinn; Carol L Sabourin; Jarad M Schiffer; Nancy A Niemuth; Vera A Semenova; Han Li; Thomas L Rudge; April M Brys; Robert S Mittler; Chris C Ibegbu; Jens Wrammert; Rafi Ahmed; Scott D Parker; Janiine Babcock; Wendy Keitel; Gregory A Poland; Harry L Keyserling; Hana El Sahly; Robert M Jacobson; Nina Marano; Brian D Plikaytis; Jennifer G Wright
Journal:  Clin Vaccine Immunol       Date:  2016-04-04

6.  Deterministic models of inhalational anthrax in New Zealand white rabbits.

Authors:  Bradford Gutting
Journal:  Biosecur Bioterror       Date:  2014-02-14

7.  Modelling respiratory infection control measure effects.

Authors:  C M Liao; S C Chen; C F Chang
Journal:  Epidemiol Infect       Date:  2007-05-16       Impact factor: 2.451

8.  Recommendations for modeling disaster responses in public health and medicine: a position paper of the society for medical decision making.

Authors:  Margaret L Brandeau; Jessica H McCoy; Nathaniel Hupert; Jon-Erik Holty; Dena M Bravata
Journal:  Med Decis Making       Date:  2009-07-15       Impact factor: 2.583

9.  Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.

Authors:  Demetrios N Kyriacou; Debra Dobrez; Jorge P Parada; Justin M Steinberg; Adam Kahn; Charles L Bennett; Brian P Schmitt
Journal:  Biosecur Bioterror       Date:  2012-07-30

10.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.